Abstract

Cryptocaryone (CPC) is a bioactive dihydrochalcone derived from Cryptocarya plants, and its antiproliferation was rarely reported, especially for ovarian cancer (OVCA). This study aimed to examine the regulation ability and mechanism of CPC on three histotypes of OVCA cells (SKOV3, TOV-21G, and TOV-112D). In a 24 h MTS assay, CPC showed antiproliferation effects to OVCA cells, i.e., IC50 values 1.5, 3, and 9.5 μM for TOV-21G, SKOV3, and TOV-112D cells. TOV-21G and SKOV3 cells showed hypersensitivity to CPC when applied for exposure time and concentration experiments. For biological processes, CPC stimulated the generation of reactive oxygen species and mitochondrial superoxide and promoted mitochondrial membrane potential dysfunction in TOV-21G and SKOV3 cells. Apoptosis was detected in OVCA cells through subG1 accumulation and annexin V staining. Apoptosis signaling such as caspase 3/7 activities, cleaved poly (ADP-ribose) polymerase, and caspase 3 expressions were upregulated by CPC. Specifically, the intrinsic and extrinsic apoptotic caspase 9 and caspase 8 were overexpressed in OVCA cells following CPC treatment. Moreover, CPC also stimulated DNA damages in terms of γH2AX expression and increased γH2AX foci. CPC also induced 8-hydroxy-2′-deoxyguanosine DNA damages. These CPC-associated principal biological processes were validated to be oxidative stress-dependent by N-acetylcysteine. In conclusion, CPC is a potential anti-OVCA natural product showing oxidative stress-dependent antiproliferation, apoptosis, and DNA damaging functions.

Highlights

  • Ovarian cancer (OVCA) commonly shows a poor prognosis when detected late

  • The present study aimed to evaluate the impact and mechanism of CPC on inhibiting cell proliferation of several OVCA cell lines (SKOV3, TOV-112D, and TOV-21G)

  • Most of them were investigated for natural products from Cryptocarya species, which identified several bioactive compounds and reported the cytotoxicity for cancer cell lines without providing antiproliferation mechanisms

Read more

Summary

Introduction

Ovarian cancer (OVCA) commonly shows a poor prognosis when detected late. OVCA was listed as the five leading causes of cancer death in the United States by age and sex in2018 [1]. Ovarian cancer (OVCA) commonly shows a poor prognosis when detected late. OVCA was listed as the five leading causes of cancer death in the United States by age and sex in. In the United States 2021 Cancer Statistics [1], the estimated new cases were 21,410, and estimated deaths were 13,770 for OVCA patients. The heterogeneity of OVCA, derived from different histological types of its epithelial cells with varying profiles of mutation [2,3], challenges OVCA therapy. Chemotherapy is a supportive treatment for OVCA therapy. Chemotherapy is frequently associated with side effects [4]

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call